Paracetamol Drug not Banned in India, says Anupriya Patel
The Central Drugs Standard Control Organisation (CDSCO) has not banned the commonly used paracetamol drug in India New Delhi: The Central Drugs Standard Control Organisation (CDSCO) has not banned the…
Paracetamol Not Banned in India, Says Union Minister Amid Rumours
In a firm clarification during the Monsoon Session of Parliament, Union Minister of State for Chemicals and Fertilisers Anupriya Patel confirmed that the government has not banned the commonly used…
Health Ministry Seeks New SOPs for Plasma Fractionation Centres
New Delhi, August 6, 2025 — In a bid to overhaul the regulatory framework for plasma-derived medicines, the Union Health Ministry has proposed new guidelines for establishing and operating Plasma…
Imports of Essential Bulk Drugs Drop 12% in June on Rising Domestic API Output
New Delhi, August 5, 2025 — India’s pharmaceutical sector is showing strong signs of self-reliance, as imports of bulk drugs and drug intermediates declined for the third consecutive month in…
Pharmexcil flags export disruption risk due to COPP mandate; seeks urgent review
The Pharmaceuticals Export Promotion Council of India on Friday sought a review of a recent circular issued by the Central Drugs Standard Control Organisation, which mandates exclusive online submission of…
HC-ordered expert panel for weight loss drug may be set up by mid-July
The Central Drugs Standard Control Organization (CDSCO) is likely to begin work on forming a court-ordered expert panel to study the unregulated use of weight loss drugs by mid-July, according…
Sun Pharma Gets Relief on Packaging Norms for Pantoprazole-Levosulpiride FDC
New Delhi: In a regulatory relief to the company, the Subject Expert Committee (SEC) under the Gastroenterology and Hepatology division of the Central Drugs Standard Control Organisation (CDSCO) has recommended…
CDSCO flags 186 drugs that fail to meet quality standards
The Central Drugs Standard Control Organisation (CDSCO) has listed at least 186 drugs and formulations as not of standard quality (NSQ) in May , after both central and state testing…
DTAB asks DCGI to take up withdrawal of license for certain FDC antibiotics with SLAs
The Drugs Technical Advisory Board (DTAB) has directed the Central drug regulator to take up the matter related to withdrawal of product license for antibiotic fixed dose combinations (FDCs), which…
Govt bans manufacture, sale of 35 fixed-dose combination drugs
Apex drugs regulatory body Central Drugs Standard Control Organisation (CDSCO) has directed drug controllers of all States and Union Territories to stop manufacture, sale and distribution of unapproved 35 fixed-dose…
